PHAC was a fraud carved off of Health Canada's PPHB branch, NEVER was 'CDC North'; I know, I was a Canadian epidemiologist at PPHB, my e-mail was changed & agency name, was a FRAUD on Canadians, just

name was changed in response to Naylor report, government pulled slight of hand on Canadians, same inept employees; LIONESS OF JUDAH MINISTRY correct, Health Canada DID not do Thorough REVIEW of data

"Trust The Science": No Clinical Data in Health Canada’s ‘Thorough’ Review of Latest Pfizer COVID Shot

"Trust The Science": No Clinical Data in Health Canada’s ‘Thorough’ Review of Latest Pfizer COVID Shot

Reminder: Health Canada was initially created for population control measures…PHAC, the Public Health Agency of Canada, is essentially a branch of the WHO

The employees at PHAC (some my friends) are former employees of PPHB Branch of Health Canada (I was an epidemiologist for Health Canada for 12 years and posted overseas), which oversaw SARS 1 of 2002/2003 where many Toronto people died, I think 44, needlessly, but due to ineptness and politics….inept, incompetent, came from poor inept epidemiology programs in Canada, I know, I was one until I went to Oxford and the like to fix the low-level incompetent education at Uof Toronto faculty of medicine epidemiology program. I learnt much too due to the program I did at Johns Hopkins in biowarfare, bioterrorism under Dr. DA Henderson. Tops. Then McMaster.

The rest, garbage!

Most of my colleagues at U of Toronto went on to hold senior public jobs across Canada, same ones, very inept. Hold senior jobs at Health Canada but are unqualified and inept. They know it. Just highly paid but stupid.

This is why 80 to 90% of Nursing home COVID deaths happened in Ontario, ineptness, the quality of public health in Ontario Canada is among the worst in the world…worst in Ontario, the epidemiology schools are a joke…Naylor (dean U of Toronto medical school) report did not help any…too corrupted in that Province under Ford…maybe McMaster is the best among the worst because their EBM program offers some aspect of acumen and quality. I know strong bright people from there. The rest should be shut down. Hurting Canadians, Ontarians.

Deaths happened under Ford, he must be accountable. He and they know why.

‘

By Noé Chartier December 14, 2023

Health Canada says it conducted a “thorough” review before authorizing Pfizer-BioNTech’s latest COVID-19 shot targeting an Omicron variant, but information it tabled this week indicates it’s still waiting on the pharma giant to provide clinical data.

Health Canada provided the information on Dec. 11 in response to multiple vaccine-related questions filed in an order paper by NDP MP Don Davies.

Mr. Davies asked about Health Canada’s authorization of Pfizer-BioNTech’s Comirnaty Omicron XBB.1.5 and Moderna’s Spikevax XBB.1.5 monovalent injections, and whether there is any clinical data demonstrating their efficacy and safety.

Health Canada answered that effectiveness data were provided for Moderna’s, but not for Pfizer’s.

“Pfizer-BioNTech is conducting a similar clinical trial with COMIRNATY Omicron XBB.1.5 vaccine, the results of this study will be submitted to Health Canada in response to Terms and Conditions issued as part of the approval of this vaccine,” says the health regulator.

“Immunogenicity and safety data will be provided as part of the terms and conditions of the authorization,” it added.

Health Canada says the benefit-risk profile of mRNA shots are “well understood” given they were given to hundreds of millions of people, and that safety and immunogenicity for primary series and booster doses have been “characterized” in several clinical trials.

“Considering the large body of evidence on the safety and efficacy of the mRNA COVID-19 vaccines, as well as the Real World Evidence that has accumulated over time, it is expected that the Omicron XBB.1.5 mRNA COVID-19 vaccines will elicit an immune response that will confer protection against COVID-19.”

Health Canada also said the safety and effectiveness of Pfizer’s XBB.1.5 shot is inferred from studies conducted on its previous mRNA products.

The regulator announced on Sept. 28 the approval of Pfizer-BioNTech’s XBB.1.5 product for individuals six months and older. The company had filed its submission for approval in June.

“After a thorough and independent review of the evidence, Health Canada has determined that the vaccine meets the Department's stringent safety, efficacy and quality requirements,” says Health Canada in a statement that doesn’t mention the lack of clinical data.

The Epoch Times reached out to Health Canada for comment on the matter and was referred to the department’s regulatory decision summary for the approval.

Under the tab “Why was the decision issued?” is written “Only non-clinical data was supplied to Health Canada to support the market authorization of the herein product.”

The latest COVID-19 vaccination products target a variant that is all but extinct in Canada. As of Nov. 26, XBB.1.5 accounted for around 7 percent of variants circulating in Canada, with the dominant one being EG.5.

The Health Canada document says the Public Health Agency of Canada (PHAC) is monitoring evidence from around the world to determine how well the new shots work against current and emerging variants.

PHAC says that as of Dec. 3, over 5.6 million Canadians have received an XBB.1.5 vaccine. Over 28.8 million Canadians have received at least one dose of COVID vaccination.’